Navigation Links
Peter Ell receives SNM's Georg Charles de Hevesy Nuclear Pioneer Award
Date:7/23/2008

Reston, Va.Peter J. Ell, director of the institute of nuclear medicine and chair of nuclear medicine at the University College London, U.K., was awarded the 2008 Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession. The award was presented during SNM's 55th Annual Meetingthe world's largest society for molecular imaging and nuclear medicine professionals.

"With this award, SNM recognizes Dr. Ell's pioneering efforts in laying the foundations of nuclear medicine and molecular imaging in Europe," said Alexander J. McEwan, who served as president of SNM from 2007-08. "For more than 30 years, he has practiced and taught nuclear medicine and served as editor-in-chief of Europe's premier nuclear medicine journal. He has blazed a trail in nuclear medicine and created the climate for research and development that exists in Europe today."

Ell was also recognized for his efforts in advancing molecular imaging and developing clinical applications of single photon emission computed tomography (SPECT), a technique that has become the norm across the world. He pioneered the use of HMPAO, a radiopharmaceutical tracer compound used to detect regional cerebral blood. This tracer can present physicians with a portrait of blood flow in the brain and indicate the existence of heart disease and inflammatory bowel disease. Along with other researchers, Ell initiated the use of immunoglobulin G (human IgG), a type of antibody that circulates in the blood and recognizes foreign particles that might be harmful, as well as iodobenzamide (IBZM), a radiolabeled probe that binds to the cerebral dopamine receptor and is used in neurotransmission studies and SPECT.

"It is an overwhelming delight and honor to receive this most prestigious award," said Ell. "Taking part in SNM annual meetings since 1971 has provided me with a strong sense of purpose, invaluable opportunities for networking and a constant source of inspiration for innovation. A sentiment of excitement is ever present, reinforcing the motivation to maintain and develop momentum in the application of tracer methodology in health and disease. It invigorates my desire to advance knowledge and promote better patient care across the broad spectrum of diseases."

Ell is a founding member of the European Association of Nuclear Medicine (EANM). In addition to serving as its first secretary, he was elected president of EANM in 1994 and served in this capacity for three years. Under his leadership, EANM's executive committee established the European School of Nuclear Medicine. For 13 years, Ell was also editor-in-chief of the European Journal of Nuclear Medicine and Molecular Imaging, transforming it into a major, high-quality publication. He has written articles on and taught in areas as diverse as neurology, hepatology, skeletal pathology, oncology and psychiatry.

A Fellow of the Royal College of Physicians, the Royal College of Radiology and the Academy of Medical Sciences, Ell received his medical degree in 1969 from the University of Lisbon, Portugal, and doctorate in 1981 from the University of Bern, Switzerland. He is a corresponding member of the Finnish, Swiss and German societies of Nuclear Medicine and, in addition to English, is fluent in French, Portuguese and German. He has been invited to speak at numerous medical conferences around the world, most notably the EANM and WFNMB Highlights Lectures, as well as delivering the SNM Henry N. Wagner Lecture in 2003.

Ell has published more than 600 full-length peer-reviewed manuscripts and more than 600 scientific abstracts in several leading journals. He has authored 26 book chapters, published 12 textbooks on topics related to nuclear medicine and edited another 10 books.

"Developing and applying technologies with practical utility for patient care has always been a major aim of my activity in nuclear medicine," said Ell. "Over the course of my career, I have been privileged to be a part of a number of spectacular events. It was gratifying, for example, to be part of a small team of investigators that developed the first tomographic images of brain blood flow and implemented the easy and effective technologies of sentinel lymph node biopsy and use of PET/CT in oncology."

"The list of previous recipients of this award is impressive and includes numerous Nobel laureatessuch as Ernest Lawrence, who built the world's first cyclotron for the production of radionuclides, and Glenn Seaborg, who discovered more than half a dozen new elements," said McEwan. "Ell joins a select group of scientists whose research is deemed to have had a significant impact on medicine."

Each year, SNM presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual for outstanding contributions to the field of nuclear medicine. De Hevesy received the 1943 Nobel Prize in chemistry for his work in determining the absorption, distribution, metabolism and elimination of radioactive compounds in the human body. His work led to the foundation of nuclear medicine as a tool for diagnosis and therapy and he is considered the father of nuclear medicine. SNM has given the de Hevesy Award every year since 1960 to honor groundbreaking work in the field of nuclear medicine.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Bernadette Peters Joins Board of Directors of Standing Tall, Innovative Program for Multiply Disabled Children
2. Scott D. Peters to Continue as Chairman and CEO of Grubb & Ellis Healthcare REIT
3. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
4. USC physician Anne L. Peters receives American Diabetes Associations Distinguished Clinician Award
5. Halleland Health Consulting Hires New Director of Lifescience Business Development Peter T. Bianco
6. Peter Burg Appointed as Co-Chair of the Plaintiffs Steering Committee and the Executive Committee for the Gadolinium-Based Contrast Agents Product Liability Multi-District Litigation
7. Peter G. Peterson Commits $1 Billion Toward Solving Americas Most Significant Economic Challenges
8. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
9. Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation
10. Noted Litigator Peter Diedrich Joins Musick Peeler & Garrett LLP
11. Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Childrens Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: